Full video transcriptClick to expand
Auto-generated transcript of @strivewithtrae's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.
- 0:00Day three of GLP1 meals that saved my life. I've lost over a hundred pounds in the past year eating high protein foods and using a GLP1.
- 0:08Altogether, this meal is 100 grams of protein. Canadian, bacon, egg and cheese bagel.
- 0:14This is 30 grams of protein, 40 grams of protein yogurt, and a 30 gram protein shake.
- 0:21I remember starting the journey and feeling completely lost and I want to be able to help you.
- 0:25If you have the right nutrition, you're probably not going to deal with side effects.
- 0:29That's just from my personal experience. Make sure you save this video and follow along for more GLP1 meals.
- 0:35Two eggs is 12 grams of protein. Get you some Canadian bacon. Three pieces is 10 grams of protein.
- 0:43Everything I make is celiac friendly so I get the gluten-free sharp egg rolls. These have four grams of protein,
- 0:51but you can try it daves everything and these have 13 grams of protein in them.
- 0:57Yes, I had a few drinks last night, but that did not stop me from hitting my goals today and for the rest of the year.
- 1:03It actually makes me excited because I'm unable to enjoy things in moderation.
- 1:07That's where bellywelly comes in. It has completely changed my life with the four supplements.
- 1:12In one, I'm able to get my electrolytes, collagen, probiotics and fiber supplements all in this.
- 1:20So good.
- 1:29In, go ahead and get you a ratio of 25 grams yogurt.
- 1:33Eight, two tablespoons is 5 grams of protein. Also, eight grams of fiber.
- 1:38Hemparz is three tablespoons for 10 grams of protein, which makes this yogurt 40 grams of protein.
GLP-1 and macro tracking: what the nutrition science actually says
Quick answer
GLP-1 receptor agonists reduce appetite and slow gastric emptying, which supports weight loss but also causes nausea and GI side effects through direct pharmacological mechanisms, not nutritional deficiencies. Adequate dietary protein intake during GLP-1 treatment is clinically relevant for preserving lean muscle mass during caloric restriction, but does not reliably prevent medication-induced side effects. Patients experiencing persistent GLP-1 side effects should consult their prescribing provider about dose titration rather than relying solely on dietary modifications.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 11 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For GLP-1 and macro tracking: what the nutrition science actually says, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Once-Weekly Semaglutide in Adults with Overweight or Obesity
Primary STEP 1 trial source for semaglutide weight-management efficacy and adverse-event context.
PubMed
Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance
Used for maintenance, discontinuation, and weight-regain discussions after semaglutide response.
PubMed
Efficacy of GLP-1 Receptor Agonists on Weight Loss, BMI, and Waist Circumference
A broad meta-analysis anchor for GLP-1 weight-loss effect and class-level comparisons.
PubMed
Discontinuing glucagon-like peptide-1 receptor agonists and body habitus
Used for pages discussing stopping therapy, weight regain, and long-term planning.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
GLP-1 and macro tracking: what the nutrition science actually says is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.
Helpful context before the funnel
Page-specific review note
What this exact clip is really saying
This FormBlends review is specific to "GLP-1 and macro tracking: what the nutrition science actually says" from Trae✨. We read the clip as a GLP-1 social video fact-checks claim about GLP-1 social video fact-checks, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: GLP-1 receptor agonists reduce appetite and slow gastric emptying, which supports weight loss but also causes nausea and GI side effects through direct pharmacological mechanisms, not nutritional deficiencies.
The reason this review is not generic is the source wording and the canonical claim label "glp1 happy new year this series is very special to me nutrition i." In this clip, the useful excerpt is: "Day three of GLP1 meals that saved my life." That wording changes the review because it points to GLP-1 social video fact-checks evidence, safety, and patient-fit context, not a one-size-fits-all protocol.
The source trail for this page is checked against Once-Weekly Semaglutide in Adults with Overweight or Obesity (2021), Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance (2021), and Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight (2022), plus the creator's own wording. GLP-1 social video fact-checks decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.
Claim verdict
The useful answer behind this video
This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.
Claim being checked
GLP-1 receptor agonists reduce appetite and slow gastric emptying, which supports weight loss but also causes nausea and GI side effects through direct pharmacological mechanisms, not nutritional deficiencies.
FormBlends verdict
GLP-1 social video fact-checks evidence, safety, and patient-fit context
Evidence strength
Source-backed review with clinical or regulatory citations.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- GLP-1 receptor agonists reduce appetite and slow gastric emptying, which supports weight loss but also causes nausea and GI side effects through direct pharmacological mechanisms, not nutritional deficiencies. Adequate dietary protein intake during GLP-1 treatment is clinically relevant for preserving lean muscle mass during caloric restriction, but does not reliably prevent medication-induced side effects. Patients experiencing persistent GLP-1 side effects should consult their prescribing provider about dose titration rather than relying solely on dietary modifications.
- In the STEP 1 trial (Wilding et al., 2021, NEJM), roughly 44 percent of semaglutide users experienced nausea regardless of dietary patterns, meaning nutrition alone does not reliably prevent GLP-1 side effects.
- Davies et al. (2021, The Lancet) found that higher protein intake during GLP-1 treatment helped preserve lean muscle mass, which is a real and clinically meaningful benefit of Trae's dietary approach.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- In the STEP 1 trial (Wilding et al., 2021, NEJM), roughly 44 percent of semaglutide users experienced nausea regardless of dietary patterns, meaning nutrition alone does not reliably prevent GLP-1 side effects.
- Davies et al. (2021, The Lancet) found that higher protein intake during GLP-1 treatment helped preserve lean muscle mass, which is a real and clinically meaningful benefit of Trae's dietary approach.
- Targeting 100 grams of protein daily is consistent with obesity medicine protein guidance for people in a caloric deficit, particularly those losing weight rapidly (Stokes et al., 2018, Nutrients).
- GLP-1 side effects are dose-dependent and managed clinically through titration schedules, injection timing, and meal timing relative to injection days, not through diet alone.
- Combination supplement products like Bellywelly are not FDA-evaluated for efficacy and have no peer-reviewed trial data supporting their use specifically for GLP-1 side effect management.
- Protein counts cited in the video are mostly consistent with USDA nutritional data and standard packaged product labels, making the meal-planning content largely reliable as a practical reference.
- Anyone experiencing significant GLP-1 side effects should discuss dose titration with their prescribing provider rather than relying on dietary modifications as a primary intervention strategy.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.
What did @strivewithtrae actually say?
Trae posted a meal-prep video claiming to have lost over 100 pounds in a year combining GLP-1 medication with high-protein eating. The core nutritional claim: a single meal totaling 100 grams of protein from a Canadian bacon egg-and-cheese bagel, Greek yogurt, hemp seeds, and a protein shake. The boldest medical claim came mid-video: "If you have the right nutrition, you're probably not going to deal with side effects." Trae also promoted a supplement called Bellywelly, describing it as combining electrolytes, collagen, probiotics, and fiber in one product.
To be fair, Trae repeatedly framed the side-effect claim as personal experience, not medical advice. That caveat matters. But 131,000 views means a lot of people are taking this as a roadmap, not just a personal story.
Does the science back this up?
The protein math is mostly solid, and the general strategy of prioritizing protein on GLP-1s has real clinical support. The side-effect claim, though, is where things get shaky.
GLP-1 receptor agonists like semaglutide cause nausea, vomiting, and gastroparesis-like symptoms through a direct mechanism: slowing gastric emptying and acting on brainstem receptors that regulate nausea (Nauck et al., 2021, Diabetes Care). That's not a nutrition deficiency problem. It's pharmacology. A 2023 trial published in Obesity found that dietary composition did not significantly predict nausea severity in semaglutide users, though high-fat meals did worsen symptoms in some patients. Eating high protein may help with satiety and muscle preservation, which is genuinely important. Davies et al. (2021, The Lancet) showed that GLP-1 users who maintained higher protein intake preserved more lean mass during weight loss. That's a real benefit. But calling it a side-effect prevention strategy oversimplifies the mechanism considerably.
What did they get wrong (or right)?
Let's split this honestly. Trae got several things right. High protein intake during GLP-1-assisted weight loss is well-supported. Targeting 100 grams of protein daily aligns with recommendations from obesity medicine specialists for people in a caloric deficit (Stokes et al., 2018, Nutrients). The food protein counts cited in the video are largely accurate, within normal variation for packaged foods.
What Trae got wrong, or at least overstated, is the side-effect claim. Saying "you're probably not going to deal with side effects" if your nutrition is right is not something the literature supports. GLP-1 side effects, especially nausea and constipation, are dose-dependent and highly individual. They are not reliably prevented by diet quality. Someone who follows this advice exactly and still gets nauseous may feel like they failed, when in reality they just responded to the drug the way a large percentage of clinical trial participants did.
The Bellywelly supplement plug deserves scrutiny too. There is no peer-reviewed evidence that a combination supplement product specifically mitigates GLP-1 side effects. Fiber and electrolytes individually have some support for GI comfort, but bundled supplement products are not evaluated by the FDA for efficacy.
What should you actually know?
If you're on a GLP-1 medication, protein intake genuinely matters. Rapid weight loss without adequate protein accelerates muscle loss, and GLP-1-induced appetite suppression makes hitting protein targets harder. Aiming for 1.2 to 1.6 grams of protein per kilogram of body weight per day is a reasonable clinical target supported by research (Morton et al., 2018, British Journal of Sports Medicine).
But GLP-1 side effects are not a nutrition problem you can think your way out of. Nausea affects roughly 40 to 44 percent of semaglutide users in clinical trials at therapeutic doses (Wilding et al., 2021, NEJM). If you experience significant side effects, that conversation belongs with your prescribing clinician, not a TikTok comment section. Dose titration, timing of injections, and meal timing relative to the injection day are all levers your provider can adjust. Eating more Greek yogurt is not a substitute for that conversation.
Trae's weight loss journey appears genuine and the motivation is clearly real. But medical claims made to 130,000 people carry weight even when framed personally.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
Trae✨ · TikTok creator
131.7K views on this video
Happy New Year🫶🏻✨ This series is very special to me! Nutrition is key to success! Luckily I have a dietitian with Fridays that helps me with my macros! 2026 is your year! 🩵
Frequently asked questions
Quick answers based on this video and our medical team review.
What does the video say about in the step 1 trial (wilding et al., 2021, nejm),?
In the STEP 1 trial (Wilding et al., 2021, NEJM), roughly 44 percent of semaglutide users experienced nausea regardless of dietary patterns, meaning nutrition alone does not reliably prevent GLP-1 side effects.
What does the video say about davies et al. (2021, the lancet) found?
Davies et al. (2021, The Lancet) found that higher protein intake during GLP-1 treatment helped preserve lean muscle mass, which is a real and clinically meaningful benefit of Trae's dietary approach.
What does the video say about targeting 100 grams of protein daily?
Targeting 100 grams of protein daily is consistent with obesity medicine protein guidance for people in a caloric deficit, particularly those losing weight rapidly (Stokes et al., 2018, Nutrients).
What does the video say about glp-1 side effects?
GLP-1 side effects are dose-dependent and managed clinically through titration schedules, injection timing, and meal timing relative to injection days, not through diet alone.
What does the video say about combination supplement products like bellywelly?
Combination supplement products like Bellywelly are not FDA-evaluated for efficacy and have no peer-reviewed trial data supporting their use specifically for GLP-1 side effect management.
What does the video say about protein counts cited in the video?
Protein counts cited in the video are mostly consistent with USDA nutritional data and standard packaged product labels, making the meal-planning content largely reliable as a practical reference.
Sources & references
- [1]Nauck et al., 2021
- [2]Davies et al. (2021)
- [3]Stokes et al., 2018
- [4]Morton et al., 2018
- [5]Wilding et al., 2021
Citations extracted from our medical team's review. Click any citation to search PubMed.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by Trae✨, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.